Concepedia

Janneke E. Stalenhoef

JE

Statistics

Publications

27

Citations

1.6K

H-Index

19

Active since

2006

Affiliations

Leiden University Medical Center(Current)

Haga Hospital

Radboud University Nijmegen

Medisch Centrum Haaglanden

OLVG

Janneke E. Stalenhoef is an author at Leiden University Medical Center specializing in infectious diseases, life sciences, and urinary tract infections.

ORCID

Publications per year

2006–2025

27

Publications

27

Exposure to Rifampicin Is Strongly Reduced in Patients with Tuberculosis and Type 2 Diabetes

Hanneke M. J. Nijland, Rovina Ruslami, Janneke E. Stalenhoef et al. · Clinical Infectious Diseases · 2006 · 241 citations · Full text

, , +8

Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · medRxiv · 2020 · 240 citations · Full text

, , +9

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · Nature Communications · 2021 · 160 citations · Full text

, , +13

The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus

Janneke E. Stalenhoef, Bachti Alisjahbana, Erni Juwita Nelwan et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2007 · 141 citations · Full text

, , +13

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Jurjan Aman, Erik Duijvelaar, Liza Botros et al. · The Lancet Respiratory Medicine · 2021 · 124 citations · Full text

, , +15

1–5 of 27